Nanfang Hospital, Southern Medical University
Clinical trials sponsored by Nanfang Hospital, Southern Medical University, explained in plain language.
-
New hope for blood cancer patients: drug may prevent post-transplant anemia
Disease control Not yet recruitingThis study tests whether the drug luspatercept can prevent severe anemia (low red blood cells) after a stem cell transplant in people with blood cancers who also have moderate to severe bone marrow scarring (myelofibrosis). About 196 adults aged 18-65 will be randomly assigned to…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Triple threat: new hope for liver cancer patients who failed first treatment?
Disease control Not yet recruitingThis study tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few spots and stopped responding to initial therapy. The goal is to see if this triple therapy can control the cancer longe…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Could a common heart pill make immunotherapy work better for stomach cancer?
Disease control Not yet recruitingThis study looks at whether adding beta-blockers (a type of blood pressure medicine) to standard immunotherapy before surgery can help shrink tumors in people with locally advanced stomach cancer who also have high blood pressure. About 33 participants will receive the combinatio…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Can a gas save lungs? new trial aims to cut ARDS deaths
Disease control Not yet recruitingThis study tests whether adding inhaled nitric oxide to standard care helps adults with moderate-to-severe acute respiratory distress syndrome (ARDS) survive longer. About 536 participants will receive either the gas or a placebo through a ventilator. Researchers will track death…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Herbal hope: could ancient remedy slash liver cancer risk in hepatitis b patients?
Disease control Not yet recruitingThis study tests whether adding a traditional Chinese herbal formula (Fufang Biejiaruangan) to standard antiviral therapy can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis. About 1,034 high-risk adults (ages 18-65) will be randomly assig…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New hope to stop dangerous transplant side effects
Disease control Not yet recruitingThis study aims to test whether a new drug called gecacitinib, when combined with standard anti-rejection medicine (ATG), can better prevent a serious complication called graft-versus-host disease (GVHD) after a stem cell transplant. The trial will enroll 40 adults with myelofibr…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Apr 15, 2026 16:16 UTC
-
New drug combo aims to wipe out lingering leukemia cells
Disease control Not yet recruitingThis study is testing whether a combination of two existing drugs, sorafenib and venetoclax, can help patients with acute myeloid leukemia (AML) who still have very small amounts of cancer left after their first treatment. The goal is to see if this 'pre-emptive' therapy can redu…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Apr 13, 2026 20:21 UTC
-
AI eye in the colon: new study aims to catch hidden polyps
Diagnosis Not yet recruitingThis study tests whether a computer-aided detection system can help doctors find more polyps (small growths) in the right side of the colon during a colonoscopy. About 686 adults aged 40-75 will have two colonoscopies in one session, with the AI system used in one of them. The go…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC
-
Glow-in-the-Dark probe could help surgeons spot stomach cancer edges
Diagnosis Not yet recruitingThis study tests a new fluorescent probe that makes stomach cancer cells glow, helping surgeons see exactly where the tumor ends during surgery. The probe is based on a safe human protein and will be tested on 32 stomach tissue samples in the lab. The goal is to improve accuracy …
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated May 11, 2026 20:40 UTC
-
AI therapist for breast cancer: could a chatbot ease anxiety and boost quality of life?
Symptom relief Not yet recruitingThis study tests whether a smartphone app powered by a large language model (like a smart chatbot) can improve the emotional well-being and quality of life of women with breast cancer. About 440 adult women with primary breast cancer will either use the app plus get usual care, o…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
Can better nutrition improve life for kids with brain tumors?
Knowledge-focused Not yet recruitingThis study follows 93 children aged 5-18 with brain tumors to see how their nutrition changes during radiation therapy and how it relates to their quality of life. Researchers will measure weight, diet, and well-being using questionnaires. The goal is to create a nutrition plan t…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC